arrow
D

Daria Maria Filippini

IRCCS Istituto Ortopedico Rizzoli
H指数:11
被引数:385

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Surgical Management of Parapharyngeal Metastases from Thyroid Carcinoma: A Systematic Review and Patient-Level Analysis of the Role of Lateral Neck Dissection

扁桃体旁甲状腺癌转移的手术治疗:颈侧方清扫术作用的系统评价和患者水平分析

Cancers
IF4.4
2026-08-290
OAAI
HPV circulating tumor DNA as a potential prognostic and predictive biomarker in head and neck squamous cell carcinoma: a systematic review

HPV循环肿瘤DNA作为头颈鳞状细胞癌中潜在预后和预测生物标志物:一项系统综述

2026-08-250
PRE
Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center

液态活检用于评估和监测间变性甲状腺癌中的BRAF V600E:一项三级癌症中心的真实世界研究

2026-06-230
OAAI
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy

IL-1介导的炎症促进转移性播散以及对EGFR靶向疗法的抵抗

2026-04-080
OAAI
Beyond EGFR inhibition in Head and Neck Squamous Cell Carcinoma: overcoming resistance mechanisms and novel therapeutic frontiers

头颈鳞状细胞癌中EGFR抑制之外:克服耐药机制与新型治疗前沿

2026-02-120
PRE
Survival rates in head and neck cutaneous squamous cell carcinoma with nodal metastases: a multicenter study

头颈部皮肤鳞状细胞癌合并淋巴结转移的生存率:一项多中心研究

2026-01-010
PRE
Challenges in pathological diagnosis of rare head and neck cancers: National survey and retrospective study

罕见头颈癌病理诊断中的挑战:全国性调查和回顾性研究

2025-10-012
PRE
Clinical landscape for patients with head and neck cancers enrolled in phase I trials at a tertiary referral center

在三级转诊中心参与I期临床试验的头颈癌患者的临床现状

2025-06-300
OA
Biomarkers of response and progression to Pembrolizumab and Vorinostat combination in late-stage squamous cell carcinoma patients of different locations included in the PEVOsq basket trial
2024-03-220
PRE
Circulating HPV DNA as a potential biomarker to monitor response to the pembrolizumab and vorinostat combination in patients with squamous cell carcinoma of different locations
2024-03-220
PRE